Sophiris Bio Inc EV/EBIT
Quel est le EV/EBIT de Sophiris Bio Inc?
Le EV/EBIT de Sophiris Bio Inc est 27.44
Quelle est la définition de EV/EBIT?
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
EV/EBIT des entreprises dans Health Care secteur sur NASDAQ par rapport à Sophiris Bio Inc
Entreprises avec ev/ebit similaire à Sophiris Bio Inc
- Maxar Technologies a EV/EBIT de 27.36
- i3 Verticals Inc a EV/EBIT de 27.38
- Dow Inc a EV/EBIT de 27.38
- General Electric a EV/EBIT de 27.39
- Global X Funds a EV/EBIT de 27.40
- UV Germi SA a EV/EBIT de 27.41
- Sophiris Bio Inc a EV/EBIT de 27.44
- Fine Organic Industries a EV/EBIT de 27.45
- Apollo Pipes a EV/EBIT de 27.46
- CoreCard a EV/EBIT de 27.46
- Firm Capital Apartment Real Estate Investment Trust a EV/EBIT de 27.46
- STL Global a EV/EBIT de 27.47
- Fidelity D&D a EV/EBIT de 27.48